Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Bioequivalence Study to Compare VIMOVO Manufactured at AstraZenca AB to VIMOVO Manufactured by Patheon Pharmaceuticals and Marketed Enteric-coated Naproxen Formulation

This study has been completed.
Information provided by (Responsible Party):
AstraZeneca Identifier:
First received: March 11, 2011
Last updated: October 17, 2011
Last verified: October 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2011
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)